Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07254065 · ClinicalTrials.gov registry record · NA
Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCT
A NA study of Feasibility and Acceptability and Prevention Childhood Obesity, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT07254065: Recruiting NA study of Feasibility and Acceptability and Prevention Childhood Obesity, sponsored by Northwell Health.
NCT07254065 is a NA study of Feasibility and Acceptability and Prevention Childhood Obesity that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07254065, a NA study of Feasibility and Acceptability and Prevention Childhood Obesity, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test an online program that teaches healthy habits during pregnancy and infant to prevent early child obesity in Latino families. Specifically, this pilot trial will determine how well we can deliver and test the effects of the program, and how acceptable it is to participants. The main question it aims to answer are: • Is a randomized controlled trial of StEP OUT versus infant safety education control feasible to conduct and acceptable to participants? Researchers will compare StEP OUT to infant safety education control to see if participants enroll in and engage with the program, complete surveys, and learn the content we are teaching. Participants will: * Be assigned to receive StEP OUT or Infant Safety Education * If receiving StEP OUT, they will participant in group text chats and video calls * If receiving Infant Safety Education, they will receive periodic text messages with helpful links and tips * Respond to periodic surveys
Primary Outcome
We will use the Sekhon acceptability framework to assess affective attitude, burden, opportunity cost, perceived effectiveness, coherence, ethicality, self-efficacy and general acceptability.
Conditions Studied
Interventions
- BEHAVIORAL StEP OUT
- BEHAVIORAL Infant Safety Education
Study Locations (1)
New York
- Northwell Health - New Hyde Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-11-14 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT07254065 shows while recruiting
NCT07254065 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Feasibility and Acceptability appearing as the primary indexed condition, and to 2 interventions - of which StEP OUT is the first listed.
NCT07254065 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07254065 about?
NCT07254065 is a clinical study titled "Starting Early to Prevent Obesity Using Telehealth (StEP OUT): Pilot RCT". The goal of this clinical trial is to test an online program that teaches healthy habits during pregnancy and infant to prevent early child obesity in Latino families. Specifically, this pilot trial will determine how well we can deliver and test the effects of the program, and how acceptable it is ...
What is the current status of trial NCT07254065?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2025-11-14. Estimated completion is 2028-06-30.
What conditions does trial NCT07254065 study?
This clinical trial studies the following conditions: Feasibility and Acceptability, Prevention Childhood Obesity.
What interventions are being tested in trial NCT07254065?
The interventions under investigation include: StEP OUT (BEHAVIORAL), Infant Safety Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT07254065?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07254065 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07254065's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI